Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, PA, USA; UPMC Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.
Am J Surg. 2023 Sep;226(3):371-378. doi: 10.1016/j.amjsurg.2023.07.004. Epub 2023 Jul 5.
We aimed to evaluate the long-term outcomes of valve-sparing aortic root replacement (VSARR) versus composite aortic valve graft replacement (CAVGR) for aortic root aneurysms.
Meta-analysis of Kaplan-Meier-derived time-to-event data from studies with follow-up including propensity-score matching or propensity-score adjustment.
Six studies met our eligibility criteria, comprising 3215 patients (1770 patients treated with VSARR and 1445 patients with CAVGR). We observed a statistically significant difference for overall survival favoring VSARR (HR 0.63, 95%CI 0.49-0.82, P = 0.001), but no statistically significant difference in the risk of reoperation (HR 0.77, 95%CI 0.51-1.14, P = 0.187) in the overall follow-up. Landmark analyses revealed that, in the first 10 years after the procedure, reoperation rates were comparable between VSARR and CAVGR (HR 0.96, 95%CI 0.62-1.48, p = 0.861), but the results beyond 10 years showed improved rates of freedom from reoperation in patients undergoing VSARR (HR 0.10, 95%CI 0.01-0.78; p = 0.027).
VSARR seems to confer better long-term survival and lower risk of reoperation in the follow-up of patients treated for aortic root aneurysm when compared with CAVGR.
我们旨在评估保留瓣膜主动脉根部替换术(VSARR)与复合主动脉瓣移植物置换术(CAVGR)治疗主动脉根部瘤的长期结果。
对包括倾向评分匹配或倾向评分调整的研究进行基于 Kaplan-Meier 生存时间数据的荟萃分析。
符合入选标准的 6 项研究共纳入 3215 例患者(1770 例接受 VSARR 治疗,1445 例接受 CAVGR 治疗)。我们观察到 VSARR 组总体生存率具有统计学意义上的优势(HR 0.63,95%CI 0.49-0.82,P = 0.001),但在总体随访中,两组再次手术风险无统计学差异(HR 0.77,95%CI 0.51-1.14,P = 0.187)。里程碑分析显示,在术后 10 年内,VSARR 组和 CAVGR 组的再次手术率相当(HR 0.96,95%CI 0.62-1.48,p = 0.861),但超过 10 年后,VSARR 组患者的无再次手术生存率更高(HR 0.10,95%CI 0.01-0.78;p = 0.027)。
与 CAVGR 相比,VSARR 似乎在主动脉根部瘤患者的随访中具有更好的长期生存率和较低的再次手术风险。